[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338665-105":59,"doc-detail-338665-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","non-coding-rnas-in-breast-cancer-diagnostic-and-therapeutic-implications","Non-Coding RNAs in Breast Cancer - Diagnostic and Therapeutic Implications","","Breast cancer (BC) is a leading cause of cancer-related mortality in women and a highly heterogeneous disease with distinct histopathological and molecular subtypes, resulting in individualized prognoses. Its etiology and pathogenesis involve complex genetic alterations and dysregulated expression of numerous non-coding RNAs. These RNAs act as key regulators of DNA replication, mRNA processing/translation, differentiation, growth, and genomic stability. In BC they influence cell-cycle control, migration/invasion, and treatment resistance, supporting their value as diagnostic/prognostic biomarkers and therapeutic targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/non-coding-rnas-in-breast-cancer-diagnostic-and-therapeutic-implications/338665/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/non-coding-rnas-in-breast-cancer-diagnostic-and-therapeutic-implications/338665.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What roles do non-coding RNAs play in breast cancer?","Question",{"text":112,"@type":113},"Non-coding RNAs act as key regulators of DNA replication, mRNA processing/translation, differentiation, growth, and genomic stability. In breast cancer, they affect cell-cycle control, tumor migration/invasion, and treatment resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why are non-coding RNAs considered promising biomarkers or therapeutic targets?",{"text":117,"@type":113},"Alterations in non-coding RNA expression may contribute to breast cancer development and progression. Their dysregulation suggests potential utility as diagnostic and prognostic markers and as therapeutic targets for novel approaches.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the main objective of the review?",{"text":121,"@type":113},"The review summarizes current knowledge and aims to delineate the function of diverse classes of non-coding RNAs in breast cancer, emphasizing their potential as diagnostic/prognostic markers and therapeutic targets/tools.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338665,1790218969,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Review  \nNon-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications  \nRoman Be ˇnaˇcka 1,*, Daniela Szabóová 1, Zuzana Gul’ašová 2 and Zdenka Hertelyová 2  \nAcademic Editor: ErikA.C. Wiemer  \nReceived: 24 November 2024  \nRevised: 18 December 2024  \nAccepted: 23 December 2024  \nPublished: 26 December 2024  \nCitation: Be ˇnaˇcka, R.; Szabóová, D.; Gul’ašová, Z.; Hertelyová, Z.  \nNon-Coding RNAsin Breast Cancer: Diagnostic and Therapeutic Implications. Int. J. Mol. Sci. 2025, 26, 127. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26010127  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Pathophysiology, Medical Faculty, Pavol Jozef Šafarik University, 04011 Košice, Slovakia; [daniela.szaboova@student.upjs.sk](daniela.szaboova@student.upjs.sk)  \n2 Center of Clinical and Preclinical Research MEDIPARK, Pavol Jozef Šafarik University, 04011 Košice, Slovakia; [zuzana.gulasova@upjs.sk](zuzana.gulasova@upjs.sk) (Z.G.); [zdenka.hertelyova@upjs.sk](zdenka.hertelyova@upjs.sk) (Z.H.)  \n* Correspondence: [roman.benacka@upjs.sk](roman.benacka@upjs.sk); Tel.: +421-915433097  \nAbstract: Breast cancer (BC) is one of the most prevalent forms of cancer globally, and has recently become the leading cause of cancer-related mortality in women. BC is a heterogeneous disease comprising various histopathological and molecular subtypes with differing levels of malignancy, and each patient has an individual prognosis. Etiology and pathogenesis are complex and involve a considerable number of genetic alterationsand dozens of alterations in non-coding RNA expression. Non-coding RNAs are part of an abundant family of single-stranded RNA molecules acting as key regulators in DNA replication, mRNA processing and translation, cell differentiation, growth, and overall genomic stability. In the context of breast cancer, non-coding RNAs are involved in cell cycle control and tumor cell migration and invasion, as well as treatment resistance. Alterations in non-coding RNA expression may contribute to the development and progression of breast cancer, making them promising biomarkers and targets for novel therapeutic approaches. Currently, the use of non-coding RNAs has not yet been applied to routine practice; however, their potential has been very well studied. The present review is a literature overview of current knowledge and its objective is to delineate the function of diverse classes of non-coding RNAs in breast cancer, with a particular emphasis on their potential utility as diagnostic and prognostic markers or as therapeutic targets and tools.  \nKeywords: breast cancer; non-coding RNAs; long non-coding RNAs; microRNAs; piwi-interacting RNAs; circular RNAs; silencing RNAs; small nuclear RNA; small nucleolar RNA; biomarkers  \n1. Introduction  \nBreast cancer (BC) is one of the most prevalent cancers in humans and the most prevalent cancer in women of all races worldwide (~25% incidence) . According to the WHO, in 2022, estimated female breast cancer incidence was 2.3 million cases, constituting 11.6% of all cancer diagnoses, surpassing lung (9.4%) and colorectal cancer (8.9%) [1] . In 2020, 2.3 million women were diagnosed with BC and the mortality of female breast cancer has reached 685,000 deaths globally. The highest reported incidence of BC was in the northern hemisphere (Northern America, Northern and Western Europe), Australia and New Zealand (>80 per 100,000 females) . In contrast, Central America, Eastern and Middle Africa, and South-Central Asia reported the lowest rates (\u003C40 per 100,000) . Melanesia, Western Africa, and Micronesia/Polynesia reported the highest mortality rates (>20 per 100,000),","cbCaifqA2UbtY4Ip","https://ap.wps.com/l/cbCaifqA2UbtY4Ip","pdf",13694324,47,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What roles do non-coding RNAs play in breast cancer?\",\"answer\":\"Non-coding RNAs act as key regulators of DNA replication, mRNA processing/translation, differentiation, growth, and genomic stability. In breast cancer, they affect cell-cycle control, tumor migration/invasion, and treatment resistance.\"},{\"question\":\"Why are non-coding RNAs considered promising biomarkers or therapeutic targets?\",\"answer\":\"Alterations in non-coding RNA expression may contribute to breast cancer development and progression. Their dysregulation suggests potential utility as diagnostic and prognostic markers and as therapeutic targets for novel approaches.\"},{\"question\":\"What is the main objective of the review?\",\"answer\":\"The review summarizes current knowledge and aims to delineate the function of diverse classes of non-coding RNAs in breast cancer, emphasizing their potential as diagnostic/prognostic markers and therapeutic targets/tools.\"}]","Non-Coding RNAs in Breast Cancer - Diagnostic and Therapeutic Implications | PDF",1790024921,118,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a270413583b2e5b266f54f4f1bc11ae8.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7907899f00924846658e84a289b61d8a.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/620801aa6f42eab68023f405c3f7f7ec.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e2acf7dec2950614656815348c8a1df.webp",980,1385,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/439e12741accc48eebd6b8148155f6e4.webp",979,1384]